Depressed Myocardial Creatine Phosphokinase Activity Following Experimental Myocardial Infarction in Rabbit

¹ Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California 92037

Since creatine phosphokinase (CPK) is found predominantly in myocardial and skeletal muscle cells, in contrast to cells participating in the inflammatory response, it was considered likely that measurement of activity of this enzyme in the heart would provide a sensitive and relatively specific index of the extent of ischemic injury following acute coronary artery occlusion. Accordingly, CPK activity was measured serially following coronary artery occlusion in extracts from rabbit myocardium with gross infarction and from normal rabbit left ventricle. In addition, myocardial CPK activity was assayed in extracts from various portions of dog hearts 24 hours after ligation of the coronary artery. CPK activity of rabbit myocardium with infarction was uniformly depressed within 6 hours following coronary occlusion. After 24 hours, activity declined from 15.5±0.9 (mean±SE) to 3.4±0.3. CPK activity in whole left ventricular extracts was depressed and in general, the extent of depression was proportional to the size of the gross infarct. CPK depression in various regions of the dog heart 24 hours after coronary occlusion correlated with the extent of reduction of blood flow determined with the use of radioactively labeled microspheres. Results suggest that depression of myocardial CPK activity may be useful in estimating the extent of tissue damage following experimental coronary artery occlusion and the effect of prophylactic and therapeutic measures on the survival of myocardium in this setting.

Submitted on March 13, 1970
Accepted on July 14, 1970

This article has been cited by other articles:

				A. K. M. T. Zaman, C. J. French, D. J. Schneider, and B. E. Sobel A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart Experimental Biology and Medicine, March 1, 2009; 234(3): 246 - 254. [Abstract] [Full Text] [PDF]

				M. Buerke, D. Pruefer, D. Sankat, J. M. Carter, U. Buerke, M. Russ, A. Schlitt, I. Friedrich, J. Borgermann, C. F. Vahl, et al. Effects of Aprotinin on Gene Expression and Protein Synthesis After Ischemia and Reperfusion in Rats Circulation, September 11, 2007; 116(11_suppl): I-121 - I-126. [Abstract] [Full Text] [PDF]

				D. Pruefer, U. Buerke, M. Khalil, M. Dahm, H. Darius, H. Oelert, and M. Buerke Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 942 - 949. [Abstract] [Full Text] [PDF]

				J. Kjekshus Distribution of myocardial injury and its relation to epicardial ST-segment change after coronary occlusion in the dog Cardiovasc Res, January 1, 2000; 45(1): 109 - 110. [Full Text] [PDF]

				A. G Kleber ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia Cardiovasc Res, January 1, 2000; 45(1): 111 - 118. [Abstract] [Full Text] [PDF]

				M. Buerke, D. Prüfer, M. Dahm, H. Oelert, J. Meyer, and H. Darius Blocking of Classical Complement Pathway Inhibits Endothelial Adhesion Molecule Expression and Preserves Ischemic Myocardium from Reperfusion Injury J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 429 - 438. [Abstract] [Full Text]

				Y. Ishikawa, J. E. Saffitz, T. L. Mealman, A. M. Grace, and R. Roberts Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma Clin. Chem., March 1, 1997; 43(3): 467 - 475. [Abstract] [Full Text] [PDF]

				A. Lefer, P Tsao, N Aoki, and M. Palladino Jr Mediation of cardioprotection by transforming growth factor-beta Science, July 6, 1990; 249(4964): 61 - 64. [Abstract] [PDF]

				J. Darsinos, J. Karli, A. Pistevos, G. Levis, and S. Moulopoulos Hemodialysis with Calcium-Free Dialysate Prevents Myocardial Creatine Kinase Depletion After Brief Coronary Artery Occlusion in Dogs Angiology, January 1, 1988; 39(10): 865 - 872. [Abstract] [PDF]

				R. E. RUDE, J. E. MULLER, and B. EUGENE Efforts to Limit the Size of Myocardial Infarcts Ann Intern Med, December 1, 1981; 95(6): 736 - 761. [Abstract] [PDF]

				D Maclean, M. Fishbein, P. Maroko, and E Braunwald Hyaluronidase-induced reductions in myocardial infarct size Science, October 8, 1976; 194(4261): 199 - 200. [Abstract] [PDF]

				P. R. MAROKO and E. BRAUNWALD Modification of Myocardial Infarction Size After Coronary Occlusion Ann Intern Med, November 1, 1973; 79(5): 720 - 733. [Abstract] [PDF]

				R. ROBERTS and B. E. SOBEL Isoenzymes of Creatine Phosphokinase and Diagnosis of Myocardial Infarction Ann Intern Med, November 1, 1973; 79(5): 741 - 743. [Abstract] [PDF]